HomeEPRX • NASDAQ
Eupraxia Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.48M | -37.54% |
Net income | -7.51M | 26.58% |
Net profit margin | — | — |
Earnings per share | -0.23 | 46.23% |
EBITDA | -7.44M | 37.71% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.10M | 71.14% |
Total assets | 34.94M | 72.42% |
Total liabilities | 3.10M | -83.98% |
Total equity | 31.84M | — |
Shares outstanding | 35.85M | — |
Price to book | 65.40 | — |
Return on assets | -82.57% | — |
Return on capital | -93.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.51M | 26.58% |
Cash from operations | -5.97M | -0.13% |
Cash from investing | -43.76K | 11.40% |
Cash from financing | 31.73M | 532,658.26% |
Net change in cash | 24.44M | 568.04% |
Free cash flow | -3.23M | -142.45% |
Previous close
$3.27
Day range
$3.15 - $3.20
Year range
$2.22 - $4.48
Market cap
161.68M CAD
Avg Volume
19.16K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
Founded
2011
Headquarters
Website
Employees
33
